ETFs To Consider As Small-Cap Biotechs Make “Their Presence Felt In Every Area”

“Be it COVID vaccine or cancer research, small-cap biotech companies are making their presence felt in every area,” observes the author of today’s article, pointing to higher chances of mergers and acquisitions, the Trump tax cuts and an unprecedented amount of government stimulus as being among the factors that have helped make the segment a winner. Against this backdrop, the author highlights several small-cap/mid-cap biotech ETFs to consider. For more, CLICK HERE.